Oligonucleotide Library for High-Throughput Yeast Metabolic Engineering

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for metabolic engineering and genetic manipulation are inefficient and time-consuming due to limited selection markers and the need for successive rounds of screening to introduce or modify genes in organisms, hindering the production of chemicals, fuels, and medicines.

Innovation Solution

A method involving the synthesis of oligonucleotides encoding guide nucleic acids and donor DNA sequences, which are incorporated into plasmids and expressed in yeast cells to introduce targeted mutations, enabling the creation of libraries with comprehensive diversity and efficient recombination at specific sites, allowing for high-throughput genetic modification.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Productivity

If standard gene targeting methods using PCR-generated marker cassettes are used, then genes can be introduced or removed from organisms, but the process is time-consuming and inefficient due to limited selection markers requiring successive rounds of screening

Engineering Contradiction:
Improveefficiency of gene introductionVSAvoidtime for successive rounds of screening
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The invention segments the gene targeting process into two independent components: a plasmid backbone containing selection markers and a separate oligonucleotide containing the guide nucleic acid and donor DNA. This allows simultaneous introduction of multiple genes in a single transformation event, eliminating successive screening rounds and dramatically improving productivity.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The invention performs preliminary action by pre-synthesizing oligonucleotides with specific guide nucleic acids and donor DNA sequences before transformation. This pre-prepared oligonucleotide library enables parallel introduction of multiple genes without requiring time-consuming successive screening rounds, as all targeting information is already encoded in the oligonucleotides.

Inventive Principle:
Principle #10Preliminary action

2Adaptability or versatility

If limited selection markers are used, then the number of genes that can be removed and heterologous genes inserted is limited, but expanding selection markers would require complex additional systems

Engineering Contradiction:
Improvenumber of genes that can be modifiedVSAvoidcomplexity of selection marker system
Core Design Contradiction:
Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The invention applies universality by using a single plasmid backbone that can accommodate multiple different oligonucleotides with various guide nucleic acids and donor DNA sequences. This universal plasmid system enables modification of any gene in the host organism by simply changing the oligonucleotide, without requiring different selection marker systems for each gene targeting application.

Inventive Principle:
Principle #6Universality (Multi-functionality)

Solution Approach 2:

The oligonucleotide serves as an intermediary carrier that delivers both the guide nucleic acid and donor DNA to the host cell. This intermediary molecule enables versatile gene modification by carrying different targeting information without requiring the host cell to have multiple specialized selection marker systems, thus increasing adaptability without proportionally increasing complexity.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If conventional gene targeting methods are used, then genetic modification can be achieved, but the process lacks high-throughput capability and cannot generate comprehensive mutant libraries efficiently

Engineering Contradiction:
Improvethroughput of genetic modificationVSAvoidtime for library generation
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The invention performs preliminary action by synthesizing a library of oligonucleotides with different guide nucleic acids and donor DNA sequences before transformation. This pre-assembled oligonucleotide library can be introduced into host cells in a single high-throughput transformation event, generating comprehensive mutant libraries without the time loss associated with conventional step-by-step gene targeting methods.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention merges the plasmid backbone with the oligonucleotide containing guide nucleic acid and donor DNA into a single transformation event. This merging of components enables simultaneous introduction of multiple genes and creation of comprehensive mutant libraries in parallel, dramatically increasing throughput and reducing the time required for library generation compared to sequential conventional methods.

Inventive Principle:
Principle #5Merging (Combining)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables rapid and efficient generation of mutant yeast cells with diverse genetic modifications, significantly reducing the time and cost associated with metabolic engineering and allowing for the optimization of metabolic pathways and production of desired compounds.

Implementation Method 1

The guide nucleic acid is complementary to a target site in a nucleic acid in a yeast cell

Methodology Applied
Scientific EffectComplementary base-pairing:

Implementation Method 2

The nucleic acid-guided endonuclease breaks the nucleic acid at the target site

Methodology Applied
Scientific EffectEnzymatic catalysis: Enzyme

Implementation Method 3

The donor DNA recombines with the nucleic acid at the two regions via the two sequences which are complementary, rejoining two portions of the nucleic acid that had been separated by breakage

Methodology Applied
Scientific EffectHomologous recombination:

Data Source

PatentUS11939571B2Library-scale engineering of metabolic pathways
Publication Date: 2024.03.26 THE GENERAL HOSPITAL CORP
  • US11939571B2 patent drawing
  • US11939571B2 patent drawing
  • US11939571B2 patent drawing

AI summary

Expressing guide nucleic acids (e.g., gRNA) from the same oligonucleotide that contains donor sequence permits the high efficiency, simultaneous transformation of a population of cells with both substrates. Using oligonucleotide chip array technology, one can construct thousands of oligonucleotides with customized gRNA and donor sequence in a cost effective manner. In combination, one can efficiently modify endogenous and exogenous genes.